Profile
Sector:
HealthcareIndustry:
Medical DistributionCountry:
United StatesIPO:
25 February 2004Website:
http://www.zynex.comNext earnings report:
28 February 2025Last dividends:
05 January 2022Next dividends:
N/APrice
after hours | Fri, 01 Nov 2024 20:06:33 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
ZYXI Latest News
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.10 per share a year ago.
Zynex Inc (NASDAQ:ZYXI) announced its third-quarter 2024 financial and operational results highlighted by a 13% year-over-year increase in orders. The pain management device company reported net revenue of $50 million for the quarter ended September 30, 2024, up slightly from $49.9 million in the prior-year period.
ENGLEWOOD, Colo. , Oct. 24, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the third quarter ended September 30, 2024.
ENGLEWOOD, Colo. , Oct. 16, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 24, 2024 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30, 2024.
Analysts expect Zynex Inc (NASDAQ:ZYXI) to return to stronger growth in 2025, driven by product diversification, sales force expansion, and upcoming product launches. The company's strategic initiatives are seen as laying the groundwork for long-term success despite short-term hurdles.
Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard recently sat down with Proactive to discuss the medical device company's innovative solutions and impressive growth trajectory. Sandgaard highlighted how Zynex has expanded from a one-person operation 28 years ago to a company with 1,200 employees and revenues reaching $200 million.
ZYXI recently received the Food and Drug Administration clearance for its new TensWave device. TensWave is designed to provide a comprehensive pain management solution.
ENGLEWOOD, Colo. , Sept. 4, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming HC Wainwright Global Investment Conference, which is being held September 9-11, 2024.
Zynex Inc (NASDAQ:ZYXI) announced that its portable pain management device TensWave has achieved Food and Drug Administration (FDA) clearance. The prescription-only TensWave device aims to provide pain relief through TENS (Transcutaneous Electrical Nerve Stimulation) therapy, which the company highlighted has been clinically proven to reduce chronic and acute pain without needing medication.
ENGLEWOOD, Colo. , Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, today announced FDA clearance of its new TensWave device.
- 1(current)
- 2
What type of business is Zynex?
Zynex, Inc. is a manufacturer of medical equipment specializing in electrotherapeutic devices used in pain management, physical rehabilitation, neurological diagnostics, and cardiac monitoring. The company was founded in 1996 and is headquartered in Englewood, Colorado. The company designs, manufactures, and sells its own medical devices through three subsidiaries: Zynex Medical provides products for home use electrotherapy. Zynex Monitoring Solutions develops heart monitoring products for hospital use. Zynex NeuroDiagnostics develops EMG and EEG diagnostic devices for neurological clinics.
What sector is Zynex in?
Zynex is in the Healthcare sector
What industry is Zynex in?
Zynex is in the Medical Distribution industry
What country is Zynex from?
Zynex is headquartered in United States
When did Zynex go public?
Zynex initial public offering (IPO) was on 25 February 2004
What is Zynex website?
https://www.zynex.com
Is Zynex in the S&P 500?
No, Zynex is not included in the S&P 500 index
Is Zynex in the NASDAQ 100?
No, Zynex is not included in the NASDAQ 100 index
Is Zynex in the Dow Jones?
No, Zynex is not included in the Dow Jones index
When was Zynex the previous earnings report?
No data
When does Zynex earnings report?
The next expected earnings date for Zynex is 28 February 2025